Synaptogenix Inc (SNPX)

[dia76ca]

Anavex are getting 40% of the Australian trial costs. But they must cover the rest and some of the PDD and Rett costs. They have 16 of 19 trial sites now active in Spain and documents say the CRO estimates results in 5 months. As well, they have an entire platform... and are planning to bring 3-71 into the clinic in 2019 possibly in Frontotemporal dementia. They are doing preclinical work in several other indications. I understand NTRP has many other drugs as well. It will be nice to see those advance also.